You need cookies enabled


You need cookies enabled

These are to:

  • drive therapeutic breakthroughs in immune-related diseases
  • explore new strategies for the control of globally important pathogens
  • increase the likelihood of discovering important, high-value, new medicines in the UK by enhancing interactions between academia and the pharmaceutical industry. 

The project will focus on autoimmune and inflammatory disease – for example Type 1 diabetes and inflammatory bowel disease – and the looming threat posed by antimicrobial resistance.


Page last updated 26 February 2015